mometasone furoate 1 MG/ML Topical Lotion

RxCUI: 151030
RxNorm name: mometasone furoate 1 MG/ML Topical Lotion
Display name: Mometasone (Topical)
Full name: mometasone furoate 1 MG/ML Topical Lotion
Term type: SCD
Status: Active
Strength: 0.1%
Dose form: Lotion
Route: Topical
Updated: 2026-10-17 23:56:13

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 042005
Active start: 042005
Multiple ingredient: NO
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
mometasone furoate	1 MG / 1 ML	mometasone	mometasone furoate

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Topical Lotion	316983

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
mometasone	108118

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	mometasone furoate 1 MG/ML Topical Lotion	1	NAMES
RxNorm Name	mometasone furoate 1 MG/ML Topical Lotion	1	NAMES
RxNorm Synonym	mometasone furoate 0.1 % Topical Lotion	1	NAMES
TTY	SCD	1	ATTRIBUTES
SPL_SET_ID	6 linked values 1ebaac16-432e-4e92-9d58-718bd76ae368 5f1f2136-9e10-4d43-bb35-ed285c744fe4 6c7d8133-b71e-4290-bec1-53ff0232998a 96eafc06-0354-49ca-a684-a77bb2afc8f5 7296b4a2-f180-4887-a8e0-029f81aec566 d15edb8b-c8b2-4023-992e-f79cefa2d1e8	6	CODES
RxCUI	151030	1	CODES
MMSL_CODE	3 linked values BD198 CD198 CD29913	3	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
21922-072-01	21922-072	MOMETASONE FUROATE MOMETASONE FUROATE	Encube Ethicals, Inc.	ANDA076499
21922-072-21	21922-072	MOMETASONE FUROATE MOMETASONE FUROATE	Encube Ethicals, Inc.	ANDA076499
45802-118-46	45802-118	Mometasone Furoate Mometasone Furoate	Padagis Israel Pharmaceuticals Ltd	ANDA077180
45802-118-59	45802-118	Mometasone Furoate Mometasone Furoate	Padagis Israel Pharmaceuticals Ltd	ANDA077180
63629-8685-1	63629-8685	Mometasone Furoate Mometasone Furoate	Bryant Ranch Prepack	ANDA077180
72162-1392-3	72162-1392	Mometasone Furoate Mometasone Furoate	Bryant Ranch Prepack	ANDA077180
72162-1392-6	72162-1392	Mometasone Furoate Mometasone Furoate	Bryant Ranch Prepack	ANDA077180

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
ANDA076499	21922-072	MOMETASONE FUROATE MOMETASONE FUROATE	ANDA	Encube Ethicals, Inc.
ANDA077180	45802-118	Mometasone Furoate Mometasone Furoate	ANDA	Padagis Israel Pharmaceuticals Ltd

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 38 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00168027230	rxnav_ndcs	yes
00168027260	rxnav_ndcs	yes
00713070185	rxnav_ndcs	yes
00781706730	rxnav_ndcs	yes
00781706761	rxnav_ndcs	yes
21922007201	rxnav_ndcs	yes
21922007221	rxnav_ndcs	yes
45802011846	rxnav_ndcs	yes
45802011859	rxnav_ndcs	yes
51672130503	rxnav_ndcs	yes
51672130504	rxnav_ndcs	yes
63629868501	rxnav_ndcs	yes
63629868601	rxnav_ndcs	yes
68462038502	rxnav_ndcs	yes
68462038537	rxnav_ndcs	yes
72162139203	rxnav_ndcs	yes
72162139206	rxnav_ndcs	yes
00085085401	rxnav_historical
00085085402	rxnav_historical
00115147154	rxnav_historical
00115147155	rxnav_historical
00713070153	rxnav_historical
00713070160	rxnav_historical
25463027230	rxnav_historical
25463027260	rxnav_historical
54868222400	rxnav_historical
54868375700	rxnav_historical
54868375701	rxnav_historical
59930154702	rxnav_historical
59930154703	rxnav_historical
61360130503	rxnav_historical_indirect
61360130504	rxnav_historical_indirect
63646011401	rxnav_historical_indirect
63646011402	rxnav_historical_indirect
67405027530	rxnav_historical
67405027560	rxnav_historical
67438011846	rxnav_historical_indirect
67438011859	rxnav_historical_indirect

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MOMETASONE FUROATE	MOMETASONE FUROATE	Encube Ethicals, Inc.	1ebaac16-432e-4e92-9d58-718bd76ae368	2025-09-15	Warnings, Adverse reactions	Exact identifier ndc (package): 21922-072-21 ndc (package): 21922-072-01 ndc (product): 21922-072 ndc11 (package): 21922007201 ndc11 (package): 21922007221 rxcui: 151030
Mometasone Furoate	MOMETASONE FUROATE	Bryant Ranch Prepack	6c7d8133-b71e-4290-bec1-53ff0232998a	2024-08-30	Warnings, Adverse reactions	Exact identifier ndc11 (package): 63629868601 rxcui: 151030
Mometasone Furoate	MOMETASONE FUROATE	Bryant Ranch Prepack	d15edb8b-c8b2-4023-992e-f79cefa2d1e8	2023-08-16	Warnings, Adverse reactions	Exact identifier ndc (package): 72162-1392-3 ndc (package): 72162-1392-6 ndc (product): 72162-1392 ndc11 (package): 72162139203 ndc11 (package): 72162139206 rxcui: 151030
Mometasone Furoate	MOMETASONE FUROATE	Bryant Ranch Prepack	5f1f2136-9e10-4d43-bb35-ed285c744fe4	2023-07-18	Warnings, Adverse reactions	Exact identifier ndc (package): 63629-8685-1 ndc (product): 63629-8685 ndc11 (package): 63629868501 rxcui: 151030
Mometasone Furoate	MOMETASONE FUROATE	Padagis Israel Pharmaceuticals Ltd	7296b4a2-f180-4887-a8e0-029f81aec566	2023-04-21	Warnings, Adverse reactions	Exact identifier ndc (package): 45802-118-59 ndc (package): 45802-118-46 ndc (product): 45802-118 ndc11 (package): 45802011859 ndc11 (package): 45802011846 rxcui: 151030

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 9 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
6c7d8133-b71e-4290-bec1-53ff0232998a	mometasone furoate 0.1 % Topical Solution (Lotion) [PSN] · mometasone furoate 1 MG/ML Topical Lotion [SCD] · mometasone furoate 0.1 % Topical Lotion [SY]	3	108	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION . MOMETASONE FUROATE topical solution, for topical use Initial U.S. Approval: 1987	20240830
5f1f2136-9e10-4d43-bb35-ed285c744fe4	mometasone furoate 0.1 % Topical Solution (Lotion) [PSN] · mometasone furoate 1 MG/ML Topical Lotion [SCD] · mometasone furoate 0.1 % Topical Lotion [SY]	3	105	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION . MOMETASONE FUROATE topical solution, for topical use Initial U.S. Approval: 1987	20230718
d15edb8b-c8b2-4023-992e-f79cefa2d1e8	mometasone furoate 0.1 % Topical Solution (Lotion) [PSN] · mometasone furoate 1 MG/ML Topical Lotion [SCD] · mometasone furoate 0.1 % Topical Lotion [SY]	3	100	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION . MOMETASONE FUROATE topical solution, for topical use Initial U.S. Approval: 1987	20230816
96eafc06-0354-49ca-a684-a77bb2afc8f5	mometasone furoate 0.1 % Topical Solution (Lotion) [PSN] · mometasone furoate 1 MG/ML Topical Lotion [SCD] · mometasone furoate 0.1 % Topical Lotion [SY]	3	10	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION. MOMETASONE FUROATE Topical Solution, 0.1% (Lotion) for topical use Initial U.S. Approval: 1987	20200531
5128842b-99e7-4517-b595-2f3b9cdce086	mometasone furoate 0.1 % Topical Solution (Lotion) [PSN] · mometasone furoate 1 MG/ML Topical Lotion [SCD] · mometasone furoate 0.1 % Topical Lotion [SY]	3	7	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION (LOTION). MOMETASONE FUROATE topical solution (lotion), for topical use Initial U.S. Approval: 1987	20250707
7296b4a2-f180-4887-a8e0-029f81aec566	mometasone furoate 0.1 % Topical Solution (Lotion) [PSN] · mometasone furoate 1 MG/ML Topical Lotion [SCD] · mometasone furoate 0.1 % Topical Lotion [SY]	3	7	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION . MOMETASONE FUROATE topical solution, for topical use Initial U.S. Approval: 1987	20230421
1ebaac16-432e-4e92-9d58-718bd76ae368	mometasone furoate 0.1 % Topical Solution (Lotion) [PSN] · mometasone furoate 1 MG/ML Topical Lotion [SCD] · mometasone furoate 0.1 % Topical Lotion [SY]	3	2	These highlights do not include all the information needed to use MOMETASONEFUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION. MOMETASONE FUROATE topical solution, for topical use Initial U.S. Approval: 1987	20250915
5839e534-ab67-4303-a20f-2861030b5170	mometasone furoate 0.1 % Topical Solution (Lotion) [PSN] · mometasone furoate 1 MG/ML Topical Lotion [SCD] · mometasone furoate 0.1 % Topical Lotion [SY]	3	2	MOMETASONE FUROATE LOTION (MOMETASONE FUROATE TOPICAL SOLUTION USP 0.1%)	20091105
1d7e21f7-00c1-4737-b663-c240badcc206	mometasone furoate 0.1 % Topical Solution (Lotion) [PSN] · mometasone furoate 1 MG/ML Topical Lotion [SCD] · mometasone furoate 0.1 % Topical Lotion [SY]	3	1	Mometasone Furoate Lotion 0.1% (mometasone furoate topical solution USP)	20060620

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
1ebaac16-432e-4e92-9d58-718bd76ae368	These highlights do not include all the information needed to use MOMETASONEFUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION. MOMETASONE FUROATE topical solution, for topical use Initial U.S. Approval: 1987	Encube Ethicals, Inc. \| Encube Ethicals Private Limited	20250915
5128842b-99e7-4517-b595-2f3b9cdce086	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION (LOTION). MOMETASONE FUROATE topical solution (lotion), for topical use Initial U.S. Approval: 1987	Sun Pharmaceutical Industries, Inc. \| Sun Pharma Canada Inc.	20250707
6c7d8133-b71e-4290-bec1-53ff0232998a	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION . MOMETASONE FUROATE topical solution, for topical use Initial U.S. Approval: 1987	Bryant Ranch Prepack	20240830
d15edb8b-c8b2-4023-992e-f79cefa2d1e8	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION . MOMETASONE FUROATE topical solution, for topical use Initial U.S. Approval: 1987	Bryant Ranch Prepack	20230816
5f1f2136-9e10-4d43-bb35-ed285c744fe4	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION . MOMETASONE FUROATE topical solution, for topical use Initial U.S. Approval: 1987	Bryant Ranch Prepack	20230718
7296b4a2-f180-4887-a8e0-029f81aec566	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION . MOMETASONE FUROATE topical solution, for topical use Initial U.S. Approval: 1987	Padagis Israel Pharmaceuticals Ltd	20230421
ce3b155b-2e84-86cc-91db-0c86bc805ab6	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION (LOTION) safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION (LOTION). MOMETASONE FUROATE Topical Solution (Lotion) for topical use Initial U.S. Approval: 1987	Cosette Pharmaceuticals, Inc.	20220624
64bd8ed7-1cc2-4cdd-94bc-9f646a88a6f0	These highlights do not include all the information needed to use ELOCON Lotion safely and effectively. See full prescribing information for ELOCON Lotion. ELOCON ® (mometasone furoate) Lotion, 0.1% for topical use Initial U.S. Approval: 1987	Merck Sharp & Dohme Corp.	20210901
96eafc06-0354-49ca-a684-a77bb2afc8f5	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION. MOMETASONE FUROATE Topical Solution, 0.1% (Lotion) for topical use Initial U.S. Approval: 1987	Glenmark Pharmaceuticals Inc., USA \| Glenmark Pharmaceuticals Limited	20200531
f0e34967-88f3-4956-b1f5-a0dff41942e9	These highlights do not include all the information needed to use MOMETASONE FUROATE TOPICAL SOLUTION safely and effectively. See full prescribing information for MOMETASONE FUROATE TOPICAL SOLUTION. MOMETASONE FUROATE topical solution Initial U.S. Approval: 1987	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	20180917
8a993241-7aa0-46cb-92ba-6e3e41dead2e		National Council for Prescription Drug Programs	20130213
3c744dc4-cfec-4148-a9a9-97c2e50ac607		National Council for Prescription Drug Programs	20130213
d2c3424c-fad5-4dc6-bc39-fec0ba9b749b		National Council for Prescription Drug Programs	20120724
c1612a70-8d24-4b0f-b9c8-862df40b4162		National Council for Prescription Drug Programs	20120724
7b28f56e-ae2a-4fe5-b37c-5b3199cae13e		National Council for Prescription Drug Programs	20120724
d47bbe5e-60b7-499d-b191-f08e137e7e4b		National Council for Prescription Drug Programs	20120724
dcaf9a72-7ad8-4cf4-83ef-a39a5d830f2d		National Council for Prescription Drug Programs	20120724
e5ddc451-f46f-4905-8e9f-1b7253b84e09		National Council for Prescription Drug Programs	20120724
ed883144-6297-4f58-96bf-5fa30b091104		National Council for Prescription Drug Programs	20120724
f99aac55-756d-4751-b5c5-714960d31c53		National Council for Prescription Drug Programs	20120724
ae85f78a-306d-4b3f-b652-feb6f23a0561		National Council for Prescription Drug Programs	20120724
8b643c1c-0495-46ac-9046-b5c1edcfbf9d		National Council for Prescription Drug Programs	20120724
86a308c1-d2b8-4220-bd29-8883ad0183a0		National Council for Prescription Drug Programs	20120724
06c83fd4-bcf3-478d-ae8f-da4e8e14c2a5		National Council for Prescription Drug Programs	20120724
565eb877-7120-459e-a56b-ef4f2949b561		National Council for Prescription Drug Programs	20120724
4062b503-6b12-493e-bede-6311f1bcdb76		National Council for Prescription Drug Programs	20120724
39023d5d-cd8e-4feb-90f5-4c6c6afb4711		National Council for Prescription Drug Programs	20120724
2d2481e6-8d6b-45a1-a85e-7d37850885ec		National Council for Prescription Drug Programs	20120724
1be739ab-884e-4a72-a652-ba4d4731f7f6		National Council for Prescription Drug Programs	20120724
5839e534-ab67-4303-a20f-2861030b5170	MOMETASONE FUROATE LOTION (MOMETASONE FUROATE TOPICAL SOLUTION USP 0.1%)	Physicians Total Care, Inc.	20091105
1D7E21F7-00C1-4737-B663-C240BADCC206	Mometasone Furoate Lotion 0.1% (mometasone furoate topical solution USP)	Warrick Pharmaceuticals Corporation	20060620

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	R01AD	Corticosteroids	ATC1-4		mometasone
ATC	D07AC	Corticosteroids, potent (group III)	ATC1-4		mometasone
ATC	D07XC	Corticosteroids, potent, other combinations	ATC1-4		mometasone
ATC	R03BA	Glucocorticoids	ATC1-4		mometasone
FDASPL	N0000175576	Corticosteroid	EPC	has_epc	mometasone
FDASPL	N0000175450	Corticosteroid Hormone Receptor Agonists	MOA	has_moa	mometasone
MEDRT	D000068656	Mometasone Furoate	CHEM	has_ingredient	mometasone
MEDRT	D000068656	Mometasone Furoate	CHEM	has_ingredient	mometasone furoate
MEDRT	D003881	Dermatomycoses	DISEASE	ci_with	mometasone
MEDRT	D003881	Dermatomycoses	DISEASE	ci_with	mometasone furoate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	mometasone furoate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	mometasone
MEDRT	D005148	Facial Dermatoses	DISEASE	may_treat	mometasone furoate
MEDRT	D005148	Facial Dermatoses	DISEASE	may_treat	mometasone
MEDRT	D005533	Foot Dermatoses	DISEASE	may_treat	mometasone
MEDRT	D005533	Foot Dermatoses	DISEASE	may_treat	mometasone furoate
MEDRT	D006229	Hand Dermatoses	DISEASE	may_treat	mometasone
MEDRT	D006229	Hand Dermatoses	DISEASE	may_treat	mometasone furoate
MEDRT	D006561	Herpes Simplex	DISEASE	ci_with	mometasone furoate
MEDRT	D006561	Herpes Simplex	DISEASE	ci_with	mometasone
MEDRT	D006562	Herpes Zoster	DISEASE	ci_with	mometasone furoate
MEDRT	D006562	Herpes Zoster	DISEASE	ci_with	mometasone
MEDRT	D006967	Hypersensitivity	DISEASE	ci_with	mometasone furoate
MEDRT	D007249	Inflammation	DISEASE	may_treat	mometasone furoate
MEDRT	D007249	Inflammation	DISEASE	may_treat	mometasone
MEDRT	D007868	Leg Dermatoses	DISEASE	may_treat	mometasone furoate
MEDRT	D007868	Leg Dermatoses	DISEASE	may_treat	mometasone
MEDRT	D011537	Pruritus	DISEASE	may_treat	mometasone furoate
MEDRT	D011537	Pruritus	DISEASE	may_treat	mometasone
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	mometasone
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	mometasone furoate
MEDRT	D012536	Scalp Dermatoses	DISEASE	may_treat	mometasone
MEDRT	D012536	Scalp Dermatoses	DISEASE	may_treat	mometasone furoate
MEDRT	D014382	Tuberculosis, Cutaneous	DISEASE	ci_with	mometasone
MEDRT	D014382	Tuberculosis, Cutaneous	DISEASE	ci_with	mometasone furoate
MEDRT	N0000000159	Glucocorticoid Receptor Agonists	MOA	has_moa	mometasone
MEDRT	N0000000159	Glucocorticoid Receptor Agonists	MOA	has_moa	mometasone furoate
MEDRT	N0000000134	Lipoxygenase Inhibitors	MOA	has_moa	mometasone
MEDRT	N0000000134	Lipoxygenase Inhibitors	MOA	has_moa	mometasone furoate
MEDRT	N0000008681	Decreased Leukotriene Activity	PE	has_pe	mometasone
MEDRT	N0000008681	Decreased Leukotriene Activity	PE	has_pe	mometasone furoate
MEDRT	N0000008834	Decreased Prostaglandin Activity	PE	has_pe	mometasone
MEDRT	N0000008834	Decreased Prostaglandin Activity	PE	has_pe	mometasone furoate
MEDRT	N0000008841	Decreased Protein Synthesis	PE	has_pe	mometasone
MEDRT	N0000008841	Decreased Protein Synthesis	PE	has_pe	mometasone furoate
MEDRT	N0000009004	Decreased Thromboxane Activity	PE	has_pe	mometasone
MEDRT	N0000009004	Decreased Thromboxane Activity	PE	has_pe	mometasone furoate
MEDRT	N0000009908	Vasoconstriction	PE	has_pe	mometasone
MEDRT	N0000009908	Vasoconstriction	PE	has_pe	mometasone furoate

Group, Type, Concept table
Group	Type	Concept	Source
DF	DF	Topical Lotion	rxnav_allrelated
DFG	DFG	Topical Product	rxnav_allrelated
IN	IN	mometasone	rxnav_allrelated
PIN	PIN	mometasone furoate	rxnav_allrelated
SCD	SCD	mometasone furoate 1 MG/ML Topical Lotion	rxnav_allrelated
SCDC	SCDC	mometasone furoate 1 MG/ML	rxnav_allrelated
SCDF	SCDF	mometasone Topical Lotion	rxnav_allrelated
SCDFP	SCDFP	mometasone furoate Topical Lotion	rxnav_allrelated
SCDG	SCDG	mometasone Topical Product	rxnav_allrelated
SCDGP	SCDGP	mometasone furoate Topical Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	1 MG/ML (expressed as mometasone furoate)
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	ANDA	ANDA076499
CODES	ANDA	ANDA077180
CODES	ANDA	ANDA090506
CODES	SNOMEDCT	332051001
CODES	VUID	4008537
CODES	VUID	4027009
NAMES	Prescribable Synonym	mometasone furoate 0.1 % Topical Solution (Lotion)
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon
SOURCES	Source	National Drug Data File Plus Source Vocabulary
SOURCES	Source	US Edition of SNOMED_CT
SOURCES	Source	Veterans Health Administration National Drug File